The WHO Global Dialogue on Partnerships for Sustainable Financing for NCD Prevention and Control was held from 9th to 11th April in Copenhagen, Denmark. The Dialogue brought together 300 participants from NCD civil society, academia, private sector, UN agencies and ministries of health and finance to discuss existing and potential sources of finance and development cooperation to close the resource gap in the NCD response.
Over the course of two and a half days the programme explored the current state of financing for NCD prevention and control, cost-effective interventions to close the resource gap, opportunities for building the investment case for NCDs, the role of partnerships and the different actors which can be involved.
Some of the key themes coming out of the discussions were:
Throughout the conference speakers highlighted new and innovative approaches to tackling NCDs, including how these responses could be financed. UICC’s CEO, Cary Adams, highlighted the work of C/Can 2025, while other speakers flagged the launch of Defeat NCDs, a new partnership working on financing and procurement for cardiovascular disease and diabetes.
One of the highlights of the conference was the launch of the Lancet Taskforce on NCDs and Economics which focuses on the economic cases for investing in NCDs as an important step to achieving the SDGs. You can read the articles from the Taskforce for free at the link above.
Speaking in the final plenary HRH Princess Dina Mired, UICC President-Elect, called the room to action by emphasising the importance of putting into practice what had been discussed at the meeting. Reflecting on the progress since 2011, Princess Dina highlighted some of the major advances seen, such as the increase in the number of national cancer control plans, but that there is a clear need for greater financing to move the ball for patients and that this, will of course, require new partners and new ways of working.